Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Brainstorm Cell Therapeutics Inc increased its cash reserves by 92.36%, or 713.00k. Cash Flow from Financing totalled 18.98m or -- of revenues. In addition the company used 20.46m for operations while cash from investing totalled 2.19m.
Cash flow per share | -3.23 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.6642 |
---|---|
Tangible book value per share | -0.6642 |
More ▼
Balance sheet in USDView more
Current ratio | 0.4962 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼